PRIMARY PERITONEAL SEROUS ADENOCARCINOMA
Clinical trials for PRIMARY PERITONEAL SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for controlling a tough ovarian cancer
Disease control CompletedThis study tested whether a drug called trametinib was better than standard treatments at controlling recurrent low-grade ovarian or peritoneal cancer. It involved 260 patients whose cancer had returned or worsened after prior chemotherapy. Participants were randomly assigned to …
Matched conditions: PRIMARY PERITONEAL SEROUS ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Doctors test personalized cancer vaccine in small ovarian cancer study
Disease control CompletedThis small, early-stage study tested a personalized vaccine for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine was made from a patient's own white blood cells, trained to target a protein found on cancer cells. The main goals were to che…
Matched conditions: PRIMARY PERITONEAL SEROUS ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC